Lecturer on Law
Scott Hirst's research interests include corporate law, securities law, and mergers and acquisitions. His recent projects have included empirical and analytical considerations of distortions that limit investor suffrage, and the agency costs associated with institutional investment. His scholarship has appeared in The Yale Journal on Regulation, The Harvard Business Law Review, and The Business Lawyer. Scott teaches the Corporate and Capital Markets Law and Policy course, and has also taught the Shareholder Rights Project Clinical Seminar.
Scott received Doctor of Juridical Science (SJD) and Master of Laws (LLM) degrees from Harvard Law School, where he was a Considine Fellow in Corporate Governance and was awarded the John M. Olin Prize in Law & Economics and the Victor Brudney Prize for Corporate Governance. His doctoral dissertation considered distortions in shareholder voting, both analytically and empirically.
Scott serves as the Associate Director of the Harvard Law School Program on Corporate Governance and Program on Institutional Investors. Before joining Harvard Law School, Scott practiced as a senior associate in the mergers and acquisitions group of Shearman & Sterling LLP in New York.
Scott also received Bachelor of Laws and Bachelor of Commerce degrees, each with First Class Honors and University Medals, from the University of Queensland in Brisbane, Australia.
Areas of Interest
Academic Appointment and Employment History
Scott is the co-founder, along with Lucian Bebchuk, and the Associate Director of the Shareholder Rights Project (SRP), which was established by the Harvard Law School Program on Institutional Investors to contribute to education, discourse, and research related to efforts by institutional investors to improve corporate governance arrangements at publicly traded firms.
From 2011 to 2014 the SRP operated a clinic that assisted institutional investors (several public pension funds and a foundation) in moving S&P 500 and Fortune 500 companies towards annual elections. This work contributed to board declassification at about 100 S&P 500 and Fortune 500 companies. With work on the declassification project completed in 2014, the clinic has not been operating during more recent academic years.